Combined analysis of ovarian cancer tissues from the TCGA database and normal ovarian tissues from the GTEx database revealed elevated levels of SLC11A2 mRNA in ovarian serous carcinoma (Fig. 2b, Supplementary Table S2). This evidence concerns the gene SLC11A2 and ovarian serous carcinoma.